Tevogen Inc.
TVGN· Nasdaq
Filed Apr 2, 2025 · 10-K · 92 days after period end · 0001641172-25-002426
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|
| Net Income | -$9.44M | -$3.63M | $2.61M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Apr 2, 2025 · 92 d after period end